{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:08:50Z","timestamp":1789643330469,"version":"4.0.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,5,20]],"date-time":"2009-05-20T00:00:00Z","timestamp":1242777600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1465-9921-10-39","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T06:13:59Z","timestamp":1242886439000},"source":"Crossref","is-referenced-by-count":56,"title":["A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice"],"prefix":"10.1186","volume":"10","author":[{"given":"Maryl\u00e8ne","family":"Fortin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"D'Anjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-\u00c8ve","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Gougeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam\u00e9la","family":"Aub\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Moktefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mouissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"S\u00e9guin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne","family":"S\u00e9guin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo M","family":"Renzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolay","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,20]]},"reference":[{"key":"753_CR1_753","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1513\/pats.200802-014ET","volume":"5","author":"V Kim","year":"2008","unstructured":"Kim V, Rogers TJ, Criner GJ: New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008, 5:478\u2013485.","journal-title":"Proc Am Thorac Soc"},{"key":"753_CR2_753","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nri2254","volume":"8","author":"PJ Barnes","year":"2008","unstructured":"Barnes PJ: Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008, 8:183\u2013192.","journal-title":"Nat Rev Immunol"},{"key":"753_CR3_753","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1183\/09031936.00018908","volume":"31","author":"KF Chung","year":"2008","unstructured":"Chung KF, Adcock IM: Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008, 31:1334\u20131356.","journal-title":"Eur Respir J"},{"issue":"2","key":"753_CR4_753","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/MCP.0b013e3282f379e9","volume":"14","author":"Pelkonen","year":"2008","unstructured":"Pelkonen : Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality. Curr Opin Pulm Med. 2008,14(2):105\u2013109.","journal-title":"Curr Opin Pulm Med."},{"key":"753_CR5_753","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0140-6736(07)61380-4","volume":"370","author":"DM Mannino","year":"2007","unstructured":"Mannino DM, Buist AS: Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007, 370:765\u2013773.","journal-title":"Lancet"},{"key":"753_CR6_753","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/thx.2004.024463","volume":"61","author":"R O'Donnell","year":"2006","unstructured":"O'Donnell R, Breen D, Wilson S, Djukanovic R: Inflammatory cells in the airways in COPD. Thorax 2006, 61:448\u2013454.","journal-title":"Thorax"},{"key":"753_CR7_753","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1378\/chest.08-0422","volume":"134","author":"AS Cowburn","year":"2008","unstructured":"Cowburn AS, Condliffe AM, Farahi N, Summers C, Chilvers ER: Advances in neutrophil biology: clinical implications. Chest 2008, 134:606\u2013612.","journal-title":"Chest"},{"key":"753_CR8_753","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1183\/09031936.98.12020380","volume":"12","author":"A Pesci","year":"1998","unstructured":"Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, Donner CF: Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J 1998, 12:380\u2013386.","journal-title":"Eur Respir J"},{"key":"753_CR9_753","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1164\/ajrccm.158.4.9802078","volume":"158","author":"A Di Stefano","year":"1998","unstructured":"Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M: Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998, 158:1277\u20131285.","journal-title":"Am J Respir Crit Care Med"},{"key":"753_CR10_753","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1378\/chest.126.6.1802","volume":"126","author":"JH Vernooy","year":"2004","unstructured":"Vernooy JH, Lindeman JH, Jacobs JA, Hanemaaijer R, Wouters EF: Increased Activity of Matrix Metalloproteinase-8 and Matrix Metalloproteinase-9 in Induced Sputum From Patients With COPD. Chest 2004, 126:1802\u20131810.","journal-title":"Chest"},{"issue":"6","key":"753_CR11_753","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/S0002-9440(10)63589-4","volume":"163","author":"SD Shapiro","year":"2003","unstructured":"Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A: Neutrophil Elastase Contributes to Cigarette Smoke-Induced Emphysema in Mice. Am J Pathol. 2003,163(6):2329\u20132335.","journal-title":"Am J Pathol."},{"issue":"3","key":"753_CR12_753","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1165\/rcmb.4791","volume":"27","author":"A Churg","year":"2002","unstructured":"Churg A, Zay K, Shay S, Xie C, Shapiro SD, Hendricks R, Wright JL: Acute Cigarette Smoke-Induced Connective Tissue Breakdown Requires both Neutrophils and Macrophage Metalloelastase in Mice. Am J Respir Cell Mol Biol. 2002,27(3):368\u2013374.","journal-title":"Am J Respir Cell Mol Biol."},{"key":"753_CR13_753","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1034\/j.1399-3003.1999.13d24.x","volume":"13","author":"RARP Peleman","year":"1999","unstructured":"Peleman RARP, Kips JC, Joos GF, Pauwels RA: The cellular composition of induced sputum in chronic obstructive pulmonary disease. Eur Respir J 1999, 13:839\u2013843.","journal-title":"Eur Respir J"},{"key":"753_CR14_753","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1164\/ajrccm.153.2.8564092","volume":"153","author":"VM Keatings","year":"1996","unstructured":"Keatings VM, Collins PD, Scott DM, Barnes PJ: Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996, 153:530\u2013534.","journal-title":"Am J Respir Crit Care Med"},{"key":"753_CR15_753","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000072006","volume":"70","author":"CWK Schulz","year":"2003","unstructured":"Schulz CWK, Harth M, Kr\u00e4tzel K, Kunz-Schughart L, Pfeifer M: Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers, and never-smokers. Respiration 2003, 70:254\u2013261.","journal-title":"Respiration"},{"key":"753_CR16_753","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/thorax.57.7.590","volume":"57","author":"SLCS Traves","year":"2002","unstructured":"Traves SLCS, Russell RE, Barnes PJ, Donnelly LE: Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax 2002, 57:590\u2013595.","journal-title":"Thorax"},{"issue":"2","key":"753_CR17_753","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1164\/ajrccm.157.2.9708012","volume":"157","author":"TJ Torphy","year":"1998","unstructured":"Torphy TJ: Phosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents. Am J Respir Crit Care Med. 1998,157(2):351\u2013370.","journal-title":"Am J Respir Crit Care Med."},{"key":"753_CR18_753","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6603(08)60718-7","volume":"63","author":"M Conti","year":"1999","unstructured":"Conti M, Jin SL: The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucleic Acid Res Mol Biol 1999, 63:1\u201338.","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"issue":"3","key":"753_CR19_753","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.4049\/jimmunol.175.3.1523","volume":"175","author":"SLC Jin","year":"2005","unstructured":"Jin SLC, Lan L, Zoudilova M, Conti M: Specific Role of Phosphodiesterase 4B in Lipopolysaccharide-Induced Signaling in Mouse Macrophages. J Immunol. 2005,175(3):1523\u20131531.","journal-title":"J Immunol."},{"issue":"12","key":"753_CR20_753","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.4049\/jimmunol.173.12.7531","volume":"173","author":"M Ariga","year":"2004","unstructured":"Ariga M, Neitzert B, Nakae S, Mottin G, Bertrand C, Pruniaux MP, Jin SL, Conti M: Nonredundant Function of Phosphodiesterases 4D and 4B in Neutrophil Recruitment to the Site of Inflammation. J Immunol. 2004,173(12):7531\u20137538.","journal-title":"J Immunol."},{"key":"753_CR21_753","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1164\/rccm.200411-1549OC","volume":"172","author":"PA Martorana","year":"2005","unstructured":"Martorana PA, Beume R, Lucattelli M, Wollin L, Lungarella G: Roflumilast Fully Prevents Emphysema in Mice Chronically Exposed to Cigarette Smoke. Am J Respir Crit Care Med 2005, 172:848\u2013853.","journal-title":"Am J Respir Crit Care Med"},{"key":"753_CR22_753","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1124\/jpet.103.053942","volume":"307","author":"H Kuss","year":"2003","unstructured":"Kuss H, Hoefgen N, Johanssen S, Kronbach TCR: In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12\u2013281), a selective phosphodiesterase 4 inhibitor for inhaled administration. J Pharmacol Exp Ther 2003, 307:373\u2013385.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"753_CR23_753","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-3565(24)29538-0","volume":"297","author":"DS Bundschuh","year":"2001","unstructured":"Bundschuh DS, Eltze M, Barsig J, Wollin L, Hatzelmann A, Beume R: In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J Pharmacol Exp Ther. 2001,297(1):280\u2013290.","journal-title":"J Pharmacol Exp Ther."},{"key":"753_CR24_753","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(05)67100-0","volume":"366","author":"KF Rabe","year":"2005","unstructured":"Rabe KF, Bateman ED, O'Donnell D, Witte S, Bredenbroker D, Bethke TD: Roflumilast-an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2005, 366:563\u2013571.","journal-title":"Lancet"},{"key":"753_CR25_753","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1365-2125.2006.02640.x","volume":"62","author":"MA Giembycz","year":"2006","unstructured":"Giembycz MA: An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease. Br J Clin Pharmacol 2006, 62:138\u2013152.","journal-title":"Br J Clin Pharmacol"},{"key":"753_CR26_753","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1378\/chest.129.1.56","volume":"129","author":"SI Rennard","year":"2006","unstructured":"Rennard SI, Schachter N, Strek M, Rickard K, Amit O: Cilomilast for COPD: Results of a 6-Month, Placebo-Controlled Study of a Potent, Selective Inhibitor of Phosphodiesterase 4. Chest 2006, 129:56\u201366.","journal-title":"Chest"},{"key":"753_CR27_753","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejphar.2005.12.059","volume":"533","author":"K Fan Chung","year":"2006","unstructured":"Fan Chung K: Phosphodiesterase inhibitors in airways disease. European Journal of Pharmacology 2006, 533:110\u2013117.","journal-title":"European Journal of Pharmacology"},{"key":"753_CR28_753","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/01926230500385549","volume":"34","author":"GN Dietsch","year":"2006","unstructured":"Dietsch GN, DiPalma CR, Eyre RJ, Pham TQ, Poole KM, Pefaur NB, Welch WD, Trueblood E, Kerns WD, Kanaly ST: Characterization of the Inflammatory Response to a Highly Selective PDE4 Inhibitor in the Rat and the Identification of Biomarkers that Correlate with Toxicity. Toxicologic Pathology 2006, 34:39\u201351.","journal-title":"Toxicologic Pathology"},{"key":"753_CR29_753","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/01926230490431493","volume":"32","author":"PEEE Losco","year":"1591","unstructured":"Losco PEEE, Barat SA, Blackshear PE, Reyderman L, Fine JS, Bober LA, Anthes JC, Mirro EJ, Cuss FM: The toxicity of SCH 35 a novel phosphodiesterase-4 inhibitor, in Cynomolgus monkeys. Toxicol Pathol 1591, 32:295\u2013308.","journal-title":"Toxicol Pathol"},{"key":"753_CR30_753","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ejphar.2007.05.074","volume":"571","author":"RW Chapman","year":"2007","unstructured":"Chapman RW, House A, Jones H, Richard J, Celly C, Prelusky D, Ting P, Hunter JC, Lamca J, Phillips JE: Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats. Eur J Pharmacol 2007, 571:215\u2013221.","journal-title":"Eur J Pharmacol"},{"key":"753_CR31_753","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.coph.2008.03.001","volume":"8","author":"PJ Barnes","year":"2008","unstructured":"Barnes PJ: Frontrunners in novel pharmacotherapy of COPD. Curr Opin Pharmacol 2008, 8:300\u2013307.","journal-title":"Curr Opin Pharmacol"},{"key":"753_CR32_753","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1378\/chest.08-1385","volume":"134","author":"PJ Barnes","year":"2008","unstructured":"Barnes PJ: Emerging pharmacotherapies for COPD. Chest 2008, 134:1278\u20131286.","journal-title":"Chest"},{"key":"753_CR33_753","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1172\/JCI0215506","volume":"110","author":"A Robichaud","year":"2002","unstructured":"Robichaud A, Stamatiou PB, Jin C, Lachance N, MacDonald D, Lalibert\u00e9 F, Liu S, Huang C, Conti M, Chan CC: Deletion of phosphodiesterase 4D in mice shortens \u03b12-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis. J Clin Invest 2002, 110:1045\u20131052.","journal-title":"J Clin Invest"},{"issue":"8","key":"753_CR34_753","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.4049\/jimmunol.178.8.4820","volume":"178","author":"D Peter","year":"2007","unstructured":"Peter D, Jin SL, Conti M, Hatzelmann A, Zitt C: Differential Expression and Function of Phosphodiesterase 4 (PDE4) Subtypes in Human Primary CD4+ T Cells: Predominant Role of PDE4D. J Immunol. 2007,178(8):4820\u20134831.","journal-title":"J Immunol."},{"key":"753_CR35_753","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1517\/13543784.16.10.1585","volume":"16","author":"L Vijayakrishnan","year":"2007","unstructured":"Vijayakrishnan L, Rudra S, Eapen MS, Dastidar S, Ray A: Small-molecule inhibitors of PDE-IV and -VII in the treatment of respiratory diseases and chronic inflammation. Expert Opinion on Investigational Drugs 2007, 16:1585\u20131599.","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"2","key":"753_CR36_753","doi-asserted-by":"publisher","first-page":"L279","DOI":"10.1152\/ajplung.00170.2002","volume":"284","author":"SJ Smith","year":"2003","unstructured":"Smith SJ, Brookes-Fazakerley S, Donnelly LE, Barnes PJ, Barnette MS, Giembycz MA: Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells. Am J Physiol Lung Cell Mol Physiol. 2003,284(2):L279-L289.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"753_CR37_753","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1124\/mol.104.002246","volume":"66","author":"SJ Smith","year":"2004","unstructured":"Smith SJ, Cieslinski LB, Newton R, Donnelly LE, Fenwick PS, Nicholson AG, Barnes PJ, Barnette MS, Giembycz MA: Discovery of BRL 50481 [3-(N, N-dimethylsulfonamido)-4-methyl-nitrobenzene], a Selective Inhibitor of Phosphodiesterase 7: In Vitro Studies in Human Monocytes, Lung Macrophages, and CD8+ T-Lymphocytes. Mol Pharmacol 2004, 66:1679\u20131689.","journal-title":"Mol Pharmacol"},{"key":"753_CR38_753","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1165\/rcmb.2005-0456OC","volume":"36","author":"JG Karras","year":"2007","unstructured":"Karras JG, Crosby JR, Guha M, Tung D, Miller DA, Gaarde WA, Geary RS, Monia BP, Gregory SA: Anti-Inflammatory Activity of Inhaled IL-4 Receptor-{alpha} Antisense Oligonucleotide in Mice. Am J Respir Cell Mol Biol 2007, 36:276\u2013285.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"753_CR39_753","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1124\/jpet.106.119214","volume":"321","author":"JR Crosby","year":"2007","unstructured":"Crosby JR, Guha M, Tung D, Miller DA, Bender B, Condon TP, York-DeFalco C, Geary RS, Monia BP, Karras JG, Gregory SA: Inhaled CD86 Antisense Oligonucleotide Suppresses Pulmonary Inflammation and Airway Hyper-responsiveness in Allergic Mice. J Pharmacol Exp Ther 2007, 321:938\u2013946.","journal-title":"J Pharmacol Exp Ther"},{"key":"753_CR40_753","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1164\/rccm.200408-1006OC","volume":"171","author":"W Duan","year":"2005","unstructured":"Duan W, Chan JH, McKay K, Crosby JR, Choo HH, Leung BP, Karras JG, Wong WS: Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice. Am J Respir Crit Care Med 2005, 171:571\u2013578.","journal-title":"Am J Respir Crit Care Med"},{"key":"753_CR41_753","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev.med.55.091902.104408","volume":"55","author":"ST Crooke","year":"2004","unstructured":"Crooke ST: Progress in Antisense Technology. Annual Review of Medicine 2004, 55:61\u201395.","journal-title":"Annual Review of Medicine"},{"key":"753_CR42_753","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2174\/138920107782109985","volume":"8","author":"NK Sahu","year":"2007","unstructured":"Sahu NK, Shilakari G, Nayak A, Kohli DV: Antisense technology: a selective tool for gene expression regulation and gene targeting. Curr Pharm Biotechnol 2007, 8:291\u2013304.","journal-title":"Curr Pharm Biotechnol"},{"key":"753_CR43_753","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2353\/ajpath.2007.070120","volume":"171","author":"R Bhindi","year":"2007","unstructured":"Bhindi R, Fahmy RG, Lowe HC, Chesterman CN, Dass CR, Cairns MJ, Saravolac EG, Sun L-Q, Khachigian LM: Brothers in Arms: DNA Enzymes, Short Interfering RNA, and the Emerging Wave of Small-Molecule Nucleic Acid-Based Gene-Silencing Strategies. Am J Pathol 2007, 171:1079\u20131088.","journal-title":"Am J Pathol"},{"key":"753_CR44_753","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/rr32","volume":"2","author":"M Tanaka","year":"2001","unstructured":"Tanaka M, Nyce J: Respirable antisense oligonucleotides: a new drug class for respiratory disease. Respiratory Research 2001, 2:5\u20139.","journal-title":"Respiratory Research"},{"key":"753_CR45_753","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2165\/00129785-200303020-00003","volume":"3","author":"H Ball","year":"2003","unstructured":"Ball H, Sandrasagra A, Tang L, Van Scott M, Wild J, Nyce J: Clinical potential of respirable antisense oligonucleotides (RASONs) in asthma. Am J Pharmacogenomics 2003, 3:97\u2013106.","journal-title":"Am J Pharmacogenomics"},{"key":"753_CR46_753","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.pupt.2008.08.001","volume":"21","author":"A Guimond","year":"2008","unstructured":"Guimond A, Viau E, Aube P, Renzi PM, Paquet L, Ferrari N: Advantageous toxicity profile of inhaled antisense oligonucleotides following chronic dosing in non-human primates. Pulm Pharmacol Ther 2008, 21:845\u2013854.","journal-title":"Pulm Pharmacol Ther"},{"key":"753_CR47_753","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1164\/rccm.200708-1251OC","volume":"177","author":"GM Gauvreau","year":"2008","unstructured":"Gauvreau GM, Boulet LP, Cockcroft DW, Baatjes A, Cote J, Deschesnes F, Davis B, Strinich T, Howie K, Duong M, Watson RM, Renzi PM, O'Byrne PM: Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Am J Respir Crit Care Med 2008, 177:952\u2013958.","journal-title":"Am J Respir Crit Care Med"},{"key":"753_CR48_753","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1081\/NCN-100002317","volume":"20","author":"MJ Damha","year":"2001","unstructured":"Damha MJ, Noronha AM, Wilds CJ, Trempe JF, Denisov A, Gehring K, Pon RT: Properties of arabinonucleic acids (ANA & 20'F-ANA): implications for the design of antisense therapeutics that invoke RNase H cleavage of RNA. Nucleosides Nucleotides Nucleic Acids 2001, 20:429\u2013440.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"753_CR49_753","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1196\/annals.1348.032","volume":"1082","author":"N Ferrari","year":"2006","unstructured":"Ferrari N, Bergeron D, Tedeschi A-L, Mangos MM, Paquet L, Renzi PM, Damha MJ: Characterization of Antisense Oligonucleotides Comprising 2'-Deoxy-2'-Fluoro-beta-D-Arabinonucleic Acid (FANA): Specificity, Potency, and Duration of Activity. Ann NY Acad Sci 2006, 1082:91\u2013102.","journal-title":"Ann NY Acad Sci"},{"key":"753_CR50_753","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1164\/rccm.200404-511OC","volume":"170","author":"A Churg","year":"2004","unstructured":"Churg A, Wang RD, Tai H, Wang X, Xie C, Wright JL: Tumor Necrosis Factor-{alpha} Drives 70% of Cigarette Smoke-induced Emphysema in the Mouse. Am J Respir Crit Care Med 2004, 170:492\u2013498.","journal-title":"Am J Respir Crit Care Med"},{"key":"753_CR51_753","doi-asserted-by":"publisher","first-page":"L612","DOI":"10.1152\/ajplung.00390.2007","volume":"294","author":"A Churg","year":"2008","unstructured":"Churg A, Cosio M, Wright JL: Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol 2008, 294:L612\u2013631.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"753_CR52_753","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","volume":"12","author":"A Zlotnik","year":"2000","unstructured":"Zlotnik A, Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121\u2013127.","journal-title":"Immunity"},{"key":"753_CR53_753","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1196\/annals.1348.047","volume":"1082","author":"Z Allakhverdi","year":"2006","unstructured":"Allakhverdi Z, Allam M, Guimond A, Ferrari N, Zemzoumi K, Seguin R, Paquet L, Renzi PM: Multitargeted Approach Using Antisense Oligonucleotides for the Treatment of Asthma. Ann NY Acad Sci 2006, 1082:62\u201373.","journal-title":"Ann NY Acad Sci"},{"issue":"7","key":"753_CR54_753","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1164\/ajrccm.165.7.2109095","volume":"165","author":"Z Allakhverdi","year":"2002","unstructured":"Allakhverdi Z, Allam M, Renzi PM: Inhibition of Antigen-induced Eosinophilia and Airway Hyperresponsiveness by Antisense Oligonucleotides Directed against the Common beta Chain of IL-3, IL-5, GM-CSF Receptors in a Rat Model of Allergic Asthma. Am J Respir Crit Care Med. 2002,165(7):1015\u20131021.","journal-title":"Am J Respir Crit Care Med."},{"key":"753_CR55_753","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1089\/oli.2006.16.203","volume":"16","author":"M Fortin","year":"2006","unstructured":"Fortin M, Ferrari N, Higgins M-E, Seguin S, Allam M, Allakhverdi Z, Piaget-Rodriguez C, Paquet L, Renzi PM: Effects of Antisense Oligodeoxynucleotides Targeting CCR3 on the Airway Response to Antigen in Rats. Oligonucleotides 2006, 16:203\u2013212.","journal-title":"Oligonucleotides"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-10-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1465-9921-10-39\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-10-39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T16:28:16Z","timestamp":1739118496000},"score":1,"resource":{"primary":{"URL":"http:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-10-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,20]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-10-39","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,20]]},"article-number":"39"}}